Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kropf

Showing results (691-700 of 862) with videos related to

Pageof 87
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2022
Randomized Trial of a Supportive Psychotherapy for Parents of Adolescents and Young Adults With Hematologic MalignanciesMichael Koehler, Susanne Hoppe, Siegfried Kropf, et al.
ACS Catalysis|November 29, 2023
Bypassing Formation of Oxide Intermediate via Chemical Vapor Deposition for the Synthesis of an Mn-N-C Catalyst with Improved ORR ActivityThomas Stracensky, Li Jiao, Qiang Sun, et al.
Oncotarget|February 5, 2016
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experienceConstantin Lapa, Katharina Lückerath, Martina Rudelius, et al.
Frontiers in Immunology|October 3, 2022
Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human bloodCorinne J Smith, Nikki Ross, Ali Kamal, et al.
Theranostics|January 3, 2017
[<sup>68</sup>Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [<sup>18</sup>F]FDG and laboratory valuesConstantin Lapa, Martin Schreder, Andreas Schirbel, et al.
Clinical Nuclear Medicine|November 8, 2016
Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer PatientsChristina Bluemel, Stefanie Hahner, Britta Heinze, et al.
Oncotarget|December 13, 2017
Targeting CXCR4 with [<sup>68</sup>Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?Constantin Lapa, Stefan Kircher, Andreas Schirbel, et al.
Biomed Research International|November 8, 2018
Insecticides Resistance Status of <i>An. gambiae</i> in Areas of Varying Agrochemical Use in Côte D'IvoireBehi K Fodjo, Benjamin G Koudou, Emmanuel Tia, et al.
The Canadian Journal of Cardiology|January 16, 2021
Right Ventricular Longitudinal Strain Predicts Survival in Patients With Functional Tricuspid RegurgitationMarwin Bannehr, Ulrike Kahn, Josephin Liebchen, et al.
Theranostics|July 9, 2019
Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [<sup>68</sup>Ga]Ga-Pentixafor-PET/MRIAlexander R Haug, Asha Leisser, Wolfgang Wadsak, et al.
Pageof 87

Showing results (691-700 of 862) with videos related to

Sort By:
Pageof 87
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2022
Randomized Trial of a Supportive Psychotherapy for Parents of Adolescents and Young Adults With Hematologic MalignanciesMichael Koehler, Susanne Hoppe, Siegfried Kropf, et al.
ACS Catalysis|November 29, 2023
Bypassing Formation of Oxide Intermediate via Chemical Vapor Deposition for the Synthesis of an Mn-N-C Catalyst with Improved ORR ActivityThomas Stracensky, Li Jiao, Qiang Sun, et al.
Oncotarget|February 5, 2016
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experienceConstantin Lapa, Katharina Lückerath, Martina Rudelius, et al.
Frontiers in Immunology|October 3, 2022
Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human bloodCorinne J Smith, Nikki Ross, Ali Kamal, et al.
Theranostics|January 3, 2017
[<sup>68</sup>Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [<sup>18</sup>F]FDG and laboratory valuesConstantin Lapa, Martin Schreder, Andreas Schirbel, et al.
Clinical Nuclear Medicine|November 8, 2016
Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer PatientsChristina Bluemel, Stefanie Hahner, Britta Heinze, et al.
Oncotarget|December 13, 2017
Targeting CXCR4 with [<sup>68</sup>Ga]Pentixafor: a suitable theranostic approach in pleural mesothelioma?Constantin Lapa, Stefan Kircher, Andreas Schirbel, et al.
Biomed Research International|November 8, 2018
Insecticides Resistance Status of <i>An. gambiae</i> in Areas of Varying Agrochemical Use in Côte D'IvoireBehi K Fodjo, Benjamin G Koudou, Emmanuel Tia, et al.
The Canadian Journal of Cardiology|January 16, 2021
Right Ventricular Longitudinal Strain Predicts Survival in Patients With Functional Tricuspid RegurgitationMarwin Bannehr, Ulrike Kahn, Josephin Liebchen, et al.
Theranostics|July 9, 2019
Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [<sup>68</sup>Ga]Ga-Pentixafor-PET/MRIAlexander R Haug, Asha Leisser, Wolfgang Wadsak, et al.
Pageof 87